BMO Capital upgraded Biogen (NASDAQ: BIIB) from Market Perform to Outperform with a price target of $381.00 (from $382.00).Analyst Ian ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE